Illumina Sets 2026 Revenue Guidance at $4.5B-$4.6B

jueves, 5 de febrero de 2026, 8:24 pm ET1 min de lectura
ILMN--

Illumina has outlined its 2026 revenue guidance of $4.5B-$4.6B, with a focus on advancing its clinical growth and multiomics strategy. In Q4 2025, the company reported 20% growth in clinical consumables revenue ex-China, exceeding expectations and reflecting strong execution across the organization.

Illumina Sets 2026 Revenue Guidance at $4.5B-$4.6B

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios